Survival of hepatitis C virus in syringes: implication for transmission among injection drug users. - Wikidata - wikimedia - TriplyDB

Survival of hepatitis C virus in syringes: implication for transmission among injection drug users.

Survival of hepatitis C virus in syringes: implication for transmission among injection drug users.

http://www.wikidata.org/entity/Q34101237

about

Epidemiology of hepatitis C in Croatia in the European context people who inject drugs, HIV risk, and HIV testing uptake in sub-Saharan Africa Per-event probability of hepatitis C infection during sharing of injecting equipment Inactivation of HCV and HIV by microwave: a novel approach for prevention of virus transmission among people who inject drugs Medical and Behavioral Approaches to Engage People Who Inject Drugs Into Care for Hepatitis C Virus Infection.Inactivation and survival of hepatitis C virus on inanimate surfaces.Hepatitis C virus seroprevalence among people who inject drugs and factors associated with infection in eight Russian cities.Improving the quality of needle and syringe programmes: an overlooked strategy for preventing hepatitis C among people who inject drugs.HIV infection risk among injection drug users in a methadone maintenance treatment program, Taipei, Taiwan 2007-2010.A multicentre sero-behavioural survey for hepatitis B and C, HIV and HTLV among people who inject drugs in Germany using respondent driven sampling HCV and HIV co-infection: mechanisms and management.Disinfection of syringes contaminated with hepatitis C virus by rinsing with household products.Intravenous Drug Users Can Achieve a High Sustained Virological Response Rate: experience From Croatian Reference Center for Viral Hepatitis Survival of Hepatitis C Virus in Syringes Is Dependent on the Design of the Syringe-Needle and Dead Space Volume.A needle in the haystack--the dire straits of needle exchange in Hungary.High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14).High dead-space syringe use among people who inject drugs in Tijuana, Mexico Factors that influence the characteristics of needles and syringes used by people who inject drugs in Tajikistan.Transmission of hepatitis C virus infection through tattooing and piercing: a critical review Understanding differences in HIV/HCV prevalence according to differentiated risk behaviors in a sample of PWID in rural Puerto Rico Transmission of hepatitis C virus among people who inject drugs: viral stability and association with drug preparation equipment.HEPATITIS C VIRUS GENOTYPES IN INJECTING DRUG USERS FROM ROMANIA.Injection drug use and hepatitis C virus infection in young adult injectors: using evidence to inform comprehensive prevention Hepatitis C virus vaccines among people who inject drugs.Global control of hepatitis C: where challenge meets opportunity Prevalence and correlates of needle-stick injuries among active duty police officers in Tijuana, Mexico.Hepatitis C virus serosorting in people who inject drugs: sorting out the details.Hepatitis C serosorting among people who inject drugs in rural Puerto Rico.Hepatitis C virus maintains infectivity for weeks after drying on inanimate surfaces at room temperature: implications for risks of transmission.Hepatitis C virus-human immunodeficiency virus coinfection.Question 2: A pointed question: is a child at risk following a community-acquired needlestick injury?Endocarditis as a Marker for New Epidemics of Injection Drug Use.Improving measurement of injection drug risk behavior using item response theory.Novel mutations in a tissue culture-adapted hepatitis C virus strain improve infectious-virus stability and markedly enhance infection kinetics.Event-level analyses of sex-risk and injection-risk behaviors among nonmedical prescription opioid users.Risk Factors Associated with Blood Exposure for Sporadic Hepatitis E in Dhaka, Bangladesh.Ebola Virus Stability Under Hospital and Environmental Conditions."Hep C, where art thou": What are the remaining (fundable) questions in hepatitis C virus research?Hepatitis C Virus Outbreaks in Hemodialysis Centers: A Continuing Problem.Mechanisms of methods for hepatitis C virus inactivation.

P2860

Q26795602-04D66ACC-6BC5-4EF1-961A-441B03A600BE Q27021365-08B39756-CDB5-4144-A372-FEA8A61C7ADF Q28540414-FFCB4214-1D92-40C0-992D-0A3BF841F6E6 Q30369227-E0B6BFB7-E7DD-418A-8AA2-5DE6916A1A3A Q33853664-44556E80-78BC-42FD-933B-8ECBFDA9DF6C Q34225779-34105EE2-AAB9-4BF4-8390-DF0FC7E09524 Q34260555-A493C384-BBFE-4362-BAE8-D04B0678F54B Q34261067-A1A98793-0B6D-4429-8419-EC4961F7B666 Q34498325-8C5A5815-3407-4906-A383-34E690817C91 Q34584310-8858B0C0-49F2-4C4C-9975-076F6FCD00ED Q35090634-888B4696-B059-4876-8D62-D882DC9EEB0A Q35628270-1D21DE04-0B43-496B-9ECB-B67D2B4A1E9A Q35764220-25D1C312-0391-455D-9AC0-BAEA8CCF8F9E Q35832272-8AF89F57-A1FD-44BD-A6E2-5DC3C6BCA7E0 Q35924703-F979FAC1-16C3-4DE0-8524-5A9DE0E475A4 Q36123087-CEE7A6CD-4FB9-4D08-97E5-EA29585C1E61 Q36155511-01A28A0B-C6DC-4F3B-A86D-E8C137989899 Q36169100-6F48BDB0-359E-4211-8750-35969F408301 Q36185545-4E79A5FD-2969-49BF-9952-D655E1B117C0 Q36668343-B669F1F8-AC24-42FB-8C5F-B4EC5C0C8982 Q36727287-5C4B4170-ADE1-4CEE-8C5B-850D7276F753 Q36761081-FBCCFC83-C3A8-47C6-B77C-802A7817C408 Q37042431-89796BFF-6E06-4550-98A6-9BB481506060 Q37042440-5CC836E7-B25A-48D0-B01B-459E89BFECC9 Q37077112-EA4A5D5C-10C4-4F6A-A22B-3E1FB12C6693 Q37110378-C1E87805-5F9C-4E74-88A1-AE5AB12BD87A Q37332212-8066CCC1-518B-4FF5-8CAC-F4A354A4D851 Q37670130-1385392B-AE80-4E17-93C4-20E82856877F Q37671939-3B8EEFDF-93E5-4AED-A539-4DE188038841 Q37972772-32523115-35EA-46F9-B7F9-D73FC58942EB Q38244110-841B486A-FB8A-4DB1-97E4-1099C888A108 Q39028798-D3D944EA-6188-4F3D-8CCB-064C6F4BD389 Q39309643-62664181-C3B5-4259-ADC0-D2DAA4D178FC Q39598862-76ED8848-36C0-4ACA-A030-D1856CA3DFBB Q39693548-BB09E331-DC81-4C15-A06F-7D8C37E69C8D Q40078243-A39E14B7-91BC-4B90-8C7E-DB6777C32B6C Q40102162-C4198B4A-7773-49C2-A72E-1F2CAAD723A3 Q40536482-50F0B181-D0C4-4988-9254-2E871F4C4E78 Q40949481-BC2B3D64-C1C3-455C-AA49-CBDCAAB26CD0 Q41589435-0B8AED33-2399-4FA8-9AA2-8EB8B74AA24C

P2860

Survival of hepatitis C virus in syringes: implication for transmission among injection drug users.

http://www.wikidata.org/entity/Q34101237

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Survival of hepatitis C virus ...... on among injection drug users.

@ast

Survival of hepatitis C virus ...... on among injection drug users.

@en

Survival of hepatitis C virus ...... on among injection drug users.

@nl

type

label

Survival of hepatitis C virus ...... on among injection drug users.

@ast

Survival of hepatitis C virus ...... on among injection drug users.

@en

Survival of hepatitis C virus ...... on among injection drug users.

@nl

prefLabel

Survival of hepatitis C virus ...... on among injection drug users.

@ast

Survival of hepatitis C virus ...... on among injection drug users.

@en

Survival of hepatitis C virus ...... on among injection drug users.

@nl

P1433

Q34101237-C06524F9-CD1B-4982-B9D1-61802DB1572A

P1476

Q34101237-323FD828-7299-4811-9282-2BA4E5ADF230

P2093

Q34101237-22255567-7513-49FD-85E8-16558E554D8F

Q34101237-9BD04DCD-C3B4-44AE-B928-067F0024DD51

Q34101237-9D1409F2-0B28-415E-B83F-37EA99243D5F

Q34101237-AD0669C0-AAFD-4351-BF3D-AAE0A1909C17

Q34101237-B5215E38-BB30-4DC5-961C-2D185D8044BD

P2860

Q34101237-0133AA98-41D6-4C3C-A987-FD346EC5D5C1

Q34101237-0A4A8612-140F-47E2-BAD1-B48A653D0C9C

Q34101237-1238B5FE-8EB1-4861-9D88-7DC5048146FE

Q34101237-13D9D5F0-C3C8-4463-8DCC-33654393B22C

Q34101237-1951F3A6-75CD-421D-B822-5DCBD2835779

Q34101237-23258846-2AEC-46F1-AD03-AAD7A9983060

Q34101237-247695B6-366E-4CA2-A458-487ABB43C61C

Q34101237-24B26DF8-8354-40E8-9DAE-DF048F8A01BF

Q34101237-28CD0B2F-293A-414A-8CA4-21C6E3B8712E

Q34101237-29145B4C-2581-437E-8069-7B03DBBFC433

P304

Q34101237-A2D22CDE-38C3-4272-B42B-4330CB5FA4B1

P31

Q34101237-30372D57-7E53-425C-B578-8954F027A2EB

P356

Q34101237-75D156BA-5281-44C8-A43F-D5B5B0F231A5

P407

Q34101237-D14648F6-F059-4DED-BBCB-07CE0132B2CA

P433

Q34101237-32A145FB-E648-4BAA-949C-55C901B06D0B

P478

Q34101237-460CF192-F644-45C7-B90E-F36CF1B16B3C

P577

Q34101237-8A60A791-BE28-4E27-BEA0-7CF277126C89

P5875

Q34101237-A97778BA-1FA2-45EB-BF44-C918BE140634

P698

Q34101237-80C0DE3D-B13F-437F-9E28-7D55B96486FD

P932

Q34101237-B446172E-7D55-4B61-A2BD-596184BB1448

P356

P1433

The Journal of Infectious Diseases

P1476

Survival of hepatitis C virus ...... on among injection drug users.

@en

P2093

Brett D Lindenbach

http://www.w3.org/2001/XMLSchema#string

Christopher Peters

http://www.w3.org/2001/XMLSchema#string

Elijah Paintsil

http://www.w3.org/2001/XMLSchema#string

Huijie He

http://www.w3.org/2001/XMLSchema#string

Robert Heimer

http://www.w3.org/2001/XMLSchema#string

P2860

The spread, treatment, and prevention of HIV-1: evolution of a global pandemic

Seroepidemiology of viral infections among intravenous drug users in northern California.

Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication.

Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro

Hepatitis C Virus p7 and NS2 Proteins Are Essential for Production of Infectious Virus

Protein Kinase A-Dependent Step(s) in Hepatitis C Virus Entry and Infectivity

Hepatitis C Virus NS2 Protein Contributes to Virus Particle Assembly via Opposing Epistatic Interactions with the E1-E2 Glycoprotein and NS3-NS4A Enzyme Complexes

Hepatitis C virus infection among drug injectors in St Petersburg, Russia: social and molecular epidemiology of an endemic infection

Complete replication of hepatitis C virus in cell culture

Hepatitis C virus infection

P304

984-990

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/656212

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

202

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45797244

http://www.w3.org/2001/XMLSchema#string

P698

20726768

http://www.w3.org/2001/XMLSchema#string

P932

2932767

http://www.w3.org/2001/XMLSchema#string